Ampac, Noramco in fine chemicals pact | March 19, 2018 Issue - Vol. 96 Issue 12 | Chemical & Engineering News
Volume 96 Issue 12 | p. 13 | Concentrates
Issue Date: March 19, 2018

Ampac, Noramco in fine chemicals pact

Department: Business
Keywords: Outsourcing, controlled substance, manufacturing

Noramco and the contract manufacturer Ampac Fine Chemicals have formed a partnership to produce controlled substances for use in treating addiction, abuse prevention, and attention deficit hyperactivity disorder. Noramco’s output will be supplemented by the former Boehringer Ingelheim plant in Petersburg, Va., that Ampac acquired in 2016. Ampac is “the first company we have found that integrates well with Noramco’s operations and strategic focus,” Noramco CEO James Mish says.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment